Vyome Holdings, Inc. is a clinical-stage healthcare holding company. The Company is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
Back to dashboard
Company Information
About this company
Key people
Krishna K Gupta
Chairman of the Board
Venkateswarlu Nelabhotla
Chief Executive Officer, Director
Jerry Leonard
Chief Financial Officer
Mohanjit Jolly
Director
Stash Pomichter
Director
Shiladitya Sengupta
Director
John Tincoff
Director
Lori Courtney Mcdougal
Independent Director
Click to see more
Key facts
- Shares in issue7.02m
- EPICHIND
- ISINUS92943X1046
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$13.12m
- Employees9
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.